BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 15192792)

  • 21. Liver transplantation for perihilar cholangiocarcinoma after aggressive neoadjuvant therapy: a new paradigm for liver and biliary malignancies?
    Heimbach JK; Gores GJ; Nagorney DM; Rosen CB
    Surgery; 2006 Sep; 140(3):331-4. PubMed ID: 16934588
    [No Abstract]   [Full Text] [Related]  

  • 22. Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not?
    Miyazaki M; Kato A; Ito H; Kimura F; Shimizu H; Ohtsuka M; Yoshidome H; Yoshitomi H; Furukawa K; Nozawa S
    Surgery; 2007 May; 141(5):581-8. PubMed ID: 17462457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus.
    Sano T; Shimada K; Sakamoto Y; Ojima H; Esaki M; Kosuge T
    Ann Surg Oncol; 2008 Feb; 15(2):590-9. PubMed ID: 18057991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver transplantation for cholangiocarcinoma.
    Rosen CB; Heimbach JK; Gores GJ
    Transpl Int; 2010 Jul; 23(7):692-7. PubMed ID: 20497401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unresectable hilar cholangiocarcinoma: multimodality approach with percutaneous treatment associated with radiotherapy and chemotherapy.
    Golfieri R; Giampalma E; Renzulli M; Galuppi A; Vicenzi L; Galaverni MC; Cappelli A
    In Vivo; 2006; 20(6A):757-60. PubMed ID: 17203762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
    Zeng ZC; Tang ZY; Fan J; Zhou J; Qin LX; Ye SL; Sun HC; Wang BL; Li D; Wang JH; Zeng MS; Guo W; Tan YS
    Cancer J; 2006; 12(2):113-22. PubMed ID: 16630402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of neoadjuvant chemoradiation on the tumor burden before liver transplantation for unresectable cholangiocarcinoma.
    Panjala C; Nguyen JH; Al-Hajjaj AN; Rosser BA; Nakhleh RE; Bridges MD; Ko SJ; Buskirk SJ; Kim GP; Harnois DM
    Liver Transpl; 2012 May; 18(5):594-601. PubMed ID: 22140024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of liver transplantation in the treatment of cholangiocarcinoma.
    Singal A; Welling TH; Marrero JA
    Expert Rev Anticancer Ther; 2009 Apr; 9(4):491-502. PubMed ID: 19374602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Combined total hepatectomy, orthotopic liver transplantation and pancreatoduodenectomy for unresectable hilar bile duct carcinoma].
    He XS; Zhang S; Zhu XF; Ji Y; Zeng JX; Ma Y; Wang DP; Ju WQ; Wu LW; Li Z; Huang JF
    Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(5):302-5. PubMed ID: 16635386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Location, not staging, of cholangiocarcinoma determines the role for adjuvant chemoradiation therapy.
    Serafini FM; Sachs D; Bloomston M; Carey LC; Karl RC; Murr MM; Rosemurgy AS
    Am Surg; 2001 Sep; 67(9):839-43; discussion 843-4. PubMed ID: 11565760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study.
    Ibrahim SM; Mulcahy MF; Lewandowski RJ; Sato KT; Ryu RK; Masterson EJ; Newman SB; Benson A; Omary RA; Salem R
    Cancer; 2008 Oct; 113(8):2119-28. PubMed ID: 18759346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience.
    Ghali P; Marotta PJ; Yoshida EM; Bain VG; Marleau D; Peltekian K; Metrakos P; Deschênes M
    Liver Transpl; 2005 Nov; 11(11):1412-6. PubMed ID: 16237695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brachytherapy in the treatment of cholangiocarcinoma.
    Shinohara ET; Guo M; Mitra N; Metz JM
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):722-8. PubMed ID: 20207503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experience of surgical resection of 103 hilar cholangiocarcinoma].
    Liang LJ; Lai JM; Li SQ; Peng BG; Yin XY; Tang D; Lü MD; Huang JF
    Zhonghua Wai Ke Za Zhi; 2006 Jul; 44(13):882-4. PubMed ID: 17067476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Retrospective analysis of 47 cases with hilar cholangiocarcinoma using T-staging system].
    Peng CH; Zhao ZM; Peng SY; Liu YB; Wu YL; Fang HQ; Jiang XC
    Zhonghua Wai Ke Za Zhi; 2005 Jan; 43(1):56-9. PubMed ID: 15774176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transplantation for hilar cholangiocarcinoma.
    Heimbach JK; Haddock MG; Alberts SR; Nyberg SL; Ishitani MB; Rosen CB; Gores GJ
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S65-8. PubMed ID: 15382214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.
    Urahashi T; Yamamoto M; Ohtsubo T; Katsuragawa H; Katagiri S; Takasaki K
    Hepatogastroenterology; 2007 Mar; 54(74):346-9. PubMed ID: 17523271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The multidisciplinary management of gastrointestinal cancer. Biliary tract cancers: from pathogenesis to endoscopic treatment.
    Demols A; Maréchal R; Devière J; Van Laethem JL
    Best Pract Res Clin Gastroenterol; 2007; 21(6):1015-29. PubMed ID: 18070701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma.
    Wakai T; Shirai Y; Moroda T; Yokoyama N; Hatakeyama K
    Cancer; 2005 Mar; 103(6):1210-6. PubMed ID: 15685618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transplantation for cholangiocarcinoma: Advance or supply-demand dilemma?
    Callery MP
    Gastroenterology; 2006 Jun; 130(7):2242-4; discussion 2244. PubMed ID: 16762651
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.